nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A8—Furosemide—dilated cardiomyopathy	0.402	0.589	CbGbCtD
Ganciclovir—SLC22A6—Furosemide—dilated cardiomyopathy	0.28	0.411	CbGbCtD
Ganciclovir—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00628	0.178	CbGpPWpGaD
Ganciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00528	0.15	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00505	0.143	CbGpPWpGaD
Ganciclovir—Breast pain—Spironolactone—dilated cardiomyopathy	0.00462	0.0163	CcSEcCtD
Ganciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0044	0.125	CbGpPWpGaD
Ganciclovir—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00413	0.0146	CcSEcCtD
Ganciclovir—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00396	0.014	CcSEcCtD
Ganciclovir—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.0038	0.0134	CcSEcCtD
Ganciclovir—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0037	0.0131	CcSEcCtD
Ganciclovir—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.00345	0.0122	CcSEcCtD
Ganciclovir—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00342	0.0972	CbGpPWpGaD
Ganciclovir—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00317	0.0112	CcSEcCtD
Ganciclovir—Blindness—Lisinopril—dilated cardiomyopathy	0.00297	0.0105	CcSEcCtD
Ganciclovir—Cholestasis—Furosemide—dilated cardiomyopathy	0.00289	0.0102	CcSEcCtD
Ganciclovir—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00283	0.00999	CcSEcCtD
Ganciclovir—Ataxia—Spironolactone—dilated cardiomyopathy	0.00275	0.00971	CcSEcCtD
Ganciclovir—Injection site pain—Furosemide—dilated cardiomyopathy	0.00268	0.00948	CcSEcCtD
Ganciclovir—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00263	0.0093	CcSEcCtD
Ganciclovir—Gastritis—Spironolactone—dilated cardiomyopathy	0.00259	0.00914	CcSEcCtD
Ganciclovir—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0025	0.00883	CcSEcCtD
Ganciclovir—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00249	0.00881	CcSEcCtD
Ganciclovir—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00244	0.0086	CcSEcCtD
Ganciclovir—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00239	0.00845	CcSEcCtD
Ganciclovir—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00233	0.00822	CcSEcCtD
Ganciclovir—Vasculitis—Furosemide—dilated cardiomyopathy	0.00225	0.00793	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00223	0.00789	CcSEcCtD
Ganciclovir—Renal failure—Spironolactone—dilated cardiomyopathy	0.00222	0.00782	CcSEcCtD
Ganciclovir—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00215	0.00758	CcSEcCtD
Ganciclovir—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0021	0.00742	CcSEcCtD
Ganciclovir—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00206	0.00726	CcSEcCtD
Ganciclovir—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00203	0.00717	CcSEcCtD
Ganciclovir—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00201	0.00711	CcSEcCtD
Ganciclovir—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00191	0.00675	CcSEcCtD
Ganciclovir—Mental disability—Furosemide—dilated cardiomyopathy	0.0019	0.00671	CcSEcCtD
Ganciclovir—Breast pain—Lisinopril—dilated cardiomyopathy	0.00188	0.00665	CcSEcCtD
Ganciclovir—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00187	0.00661	CcSEcCtD
Ganciclovir—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00184	0.00649	CcSEcCtD
Ganciclovir—Cough increased—Lisinopril—dilated cardiomyopathy	0.0018	0.00634	CcSEcCtD
Ganciclovir—Alopecia—Spironolactone—dilated cardiomyopathy	0.00179	0.00631	CcSEcCtD
Ganciclovir—Deafness—Furosemide—dilated cardiomyopathy	0.00178	0.00628	CcSEcCtD
Ganciclovir—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00176	0.00622	CcSEcCtD
Ganciclovir—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00173	0.0061	CcSEcCtD
Ganciclovir—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00169	0.00598	CcSEcCtD
Ganciclovir—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00169	0.00595	CcSEcCtD
Ganciclovir—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00169	0.00595	CcSEcCtD
Ganciclovir—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00166	0.00588	CcSEcCtD
Ganciclovir—Neck pain—Lisinopril—dilated cardiomyopathy	0.00166	0.00588	CcSEcCtD
Ganciclovir—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00164	0.00581	CcSEcCtD
Ganciclovir—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00163	0.00577	CcSEcCtD
Ganciclovir—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00162	0.0057	CcSEcCtD
Ganciclovir—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.0016	0.00564	CcSEcCtD
Ganciclovir—Malaise—Spironolactone—dilated cardiomyopathy	0.00159	0.00561	CcSEcCtD
Ganciclovir—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00158	0.00556	CcSEcCtD
Ganciclovir—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00155	0.00548	CcSEcCtD
Ganciclovir—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00154	0.00545	CcSEcCtD
Ganciclovir—Photophobia—Lisinopril—dilated cardiomyopathy	0.00154	0.00545	CcSEcCtD
Ganciclovir—Irritability—Furosemide—dilated cardiomyopathy	0.00152	0.00536	CcSEcCtD
Ganciclovir—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00149	0.00526	CcSEcCtD
Ganciclovir—Discomfort—Spironolactone—dilated cardiomyopathy	0.00148	0.00523	CcSEcCtD
Ganciclovir—Dehydration—Furosemide—dilated cardiomyopathy	0.00148	0.00522	CcSEcCtD
Ganciclovir—Confusional state—Spironolactone—dilated cardiomyopathy	0.00145	0.00512	CcSEcCtD
Ganciclovir—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00145	0.00511	CcSEcCtD
Ganciclovir—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00144	0.00509	CcSEcCtD
Ganciclovir—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00144	0.00507	CcSEcCtD
Ganciclovir—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00143	0.00506	CcSEcCtD
Ganciclovir—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00141	0.00497	CcSEcCtD
Ganciclovir—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0014	0.00495	CcSEcCtD
Ganciclovir—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00138	0.00489	CcSEcCtD
Ganciclovir—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00137	0.00482	CcSEcCtD
Ganciclovir—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00136	0.00481	CcSEcCtD
Ganciclovir—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00135	0.00476	CcSEcCtD
Ganciclovir—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00133	0.00469	CcSEcCtD
Ganciclovir—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00132	0.00467	CcSEcCtD
Ganciclovir—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00129	0.00456	CcSEcCtD
Ganciclovir—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00129	0.00454	CcSEcCtD
Ganciclovir—Somnolence—Spironolactone—dilated cardiomyopathy	0.00128	0.00451	CcSEcCtD
Ganciclovir—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00127	0.00448	CcSEcCtD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00126	0.0357	CbGpPWpGaD
Ganciclovir—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00126	0.00443	CcSEcCtD
Ganciclovir—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00125	0.00443	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00124	0.00438	CcSEcCtD
Ganciclovir—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00124	0.00438	CcSEcCtD
Ganciclovir—Arthritis—Lisinopril—dilated cardiomyopathy	0.00123	0.00434	CcSEcCtD
Ganciclovir—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00122	0.0043	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00122	0.00429	CcSEcCtD
Ganciclovir—Renal failure—Furosemide—dilated cardiomyopathy	0.00121	0.00425	CcSEcCtD
Ganciclovir—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.0012	0.00423	CcSEcCtD
Ganciclovir—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00119	0.00421	CcSEcCtD
Ganciclovir—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00118	0.00418	CcSEcCtD
Ganciclovir—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00118	0.00418	CcSEcCtD
Ganciclovir—Sweating—Furosemide—dilated cardiomyopathy	0.00118	0.00415	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00116	0.00409	CcSEcCtD
Ganciclovir—Face oedema—Lisinopril—dilated cardiomyopathy	0.00115	0.00407	CcSEcCtD
Ganciclovir—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00114	0.00404	CcSEcCtD
Ganciclovir—Urticaria—Spironolactone—dilated cardiomyopathy	0.00114	0.00403	CcSEcCtD
Ganciclovir—Irritability—Lisinopril—dilated cardiomyopathy	0.00114	0.00402	CcSEcCtD
Ganciclovir—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00114	0.00401	CcSEcCtD
Ganciclovir—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00114	0.00401	CcSEcCtD
Ganciclovir—Ataxia—Lisinopril—dilated cardiomyopathy	0.00112	0.00396	CcSEcCtD
Ganciclovir—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00112	0.00395	CcSEcCtD
Ganciclovir—Dehydration—Lisinopril—dilated cardiomyopathy	0.00111	0.00392	CcSEcCtD
Ganciclovir—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00109	0.00384	CcSEcCtD
Ganciclovir—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00108	0.00381	CcSEcCtD
Ganciclovir—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00108	0.00379	CcSEcCtD
Ganciclovir—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00107	0.00377	CcSEcCtD
Ganciclovir—Visual impairment—Furosemide—dilated cardiomyopathy	0.00106	0.00374	CcSEcCtD
Ganciclovir—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00106	0.00374	CcSEcCtD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00106	0.03	CbGpPWpGaD
Ganciclovir—Gastritis—Lisinopril—dilated cardiomyopathy	0.00106	0.00373	CcSEcCtD
Ganciclovir—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00104	0.00367	CcSEcCtD
Ganciclovir—Tinnitus—Furosemide—dilated cardiomyopathy	0.00103	0.00362	CcSEcCtD
Ganciclovir—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00102	0.00361	CcSEcCtD
Ganciclovir—Pruritus—Spironolactone—dilated cardiomyopathy	0.00102	0.00359	CcSEcCtD
Ganciclovir—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00101	0.00358	CcSEcCtD
Ganciclovir—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00101	0.00357	CcSEcCtD
Ganciclovir—Angiopathy—Furosemide—dilated cardiomyopathy	0.000999	0.00352	CcSEcCtD
Ganciclovir—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000983	0.00347	CcSEcCtD
Ganciclovir—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000983	0.00347	CcSEcCtD
Ganciclovir—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00098	0.00346	CcSEcCtD
Ganciclovir—Dysuria—Lisinopril—dilated cardiomyopathy	0.000965	0.00341	CcSEcCtD
Ganciclovir—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000965	0.00341	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000959	0.00338	CcSEcCtD
Ganciclovir—Malnutrition—Furosemide—dilated cardiomyopathy	0.000958	0.00338	CcSEcCtD
Ganciclovir—Dizziness—Spironolactone—dilated cardiomyopathy	0.00095	0.00336	CcSEcCtD
Ganciclovir—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00095	0.00335	CcSEcCtD
Ganciclovir—Flatulence—Furosemide—dilated cardiomyopathy	0.000944	0.00333	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000942	0.00332	CcSEcCtD
Ganciclovir—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000938	0.00331	CcSEcCtD
Ganciclovir—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000933	0.00329	CcSEcCtD
Ganciclovir—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000931	0.00329	CcSEcCtD
Ganciclovir—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000925	0.00327	CcSEcCtD
Ganciclovir—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000921	0.00325	CcSEcCtD
Ganciclovir—Vomiting—Spironolactone—dilated cardiomyopathy	0.000914	0.00323	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000912	0.00322	CcSEcCtD
Ganciclovir—Rash—Spironolactone—dilated cardiomyopathy	0.000906	0.0032	CcSEcCtD
Ganciclovir—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000905	0.0032	CcSEcCtD
Ganciclovir—Renal failure—Lisinopril—dilated cardiomyopathy	0.000904	0.00319	CcSEcCtD
Ganciclovir—Vision blurred—Furosemide—dilated cardiomyopathy	0.000903	0.00319	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000902	0.00318	CcSEcCtD
Ganciclovir—Headache—Spironolactone—dilated cardiomyopathy	0.0009	0.00318	CcSEcCtD
Ganciclovir—Jaundice—Lisinopril—dilated cardiomyopathy	0.000897	0.00317	CcSEcCtD
Ganciclovir—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000894	0.00316	CcSEcCtD
Ganciclovir—Anaemia—Furosemide—dilated cardiomyopathy	0.000886	0.00313	CcSEcCtD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000882	0.0251	CbGpPWpGaD
Ganciclovir—Sweating—Lisinopril—dilated cardiomyopathy	0.000882	0.00311	CcSEcCtD
Ganciclovir—Agitation—Furosemide—dilated cardiomyopathy	0.000881	0.00311	CcSEcCtD
Ganciclovir—Haematuria—Lisinopril—dilated cardiomyopathy	0.000877	0.0031	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00087	0.00307	CcSEcCtD
Ganciclovir—Vertigo—Furosemide—dilated cardiomyopathy	0.000861	0.00304	CcSEcCtD
Ganciclovir—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000859	0.00303	CcSEcCtD
Ganciclovir—Leukopenia—Furosemide—dilated cardiomyopathy	0.000858	0.00303	CcSEcCtD
Ganciclovir—Nausea—Spironolactone—dilated cardiomyopathy	0.000854	0.00301	CcSEcCtD
Ganciclovir—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000828	0.00292	CcSEcCtD
Ganciclovir—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000826	0.00292	CcSEcCtD
Ganciclovir—Hallucination—Lisinopril—dilated cardiomyopathy	0.000822	0.0029	CcSEcCtD
Ganciclovir—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00082	0.00289	CcSEcCtD
Ganciclovir—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000816	0.00288	CcSEcCtD
Ganciclovir—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000814	0.00287	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00081	0.00286	CcSEcCtD
Ganciclovir—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00081	0.00286	CcSEcCtD
Ganciclovir—Dry mouth—Furosemide—dilated cardiomyopathy	0.000798	0.00282	CcSEcCtD
Ganciclovir—Confusional state—Furosemide—dilated cardiomyopathy	0.000788	0.00278	CcSEcCtD
Ganciclovir—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000782	0.00276	CcSEcCtD
Ganciclovir—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000781	0.00276	CcSEcCtD
Ganciclovir—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00077	0.00272	CcSEcCtD
Ganciclovir—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000766	0.0027	CcSEcCtD
Ganciclovir—Skin disorder—Furosemide—dilated cardiomyopathy	0.00076	0.00268	CcSEcCtD
Ganciclovir—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000756	0.00267	CcSEcCtD
Ganciclovir—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000749	0.00264	CcSEcCtD
Ganciclovir—Anorexia—Furosemide—dilated cardiomyopathy	0.000745	0.00263	CcSEcCtD
Ganciclovir—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000744	0.00263	CcSEcCtD
Ganciclovir—Chills—Lisinopril—dilated cardiomyopathy	0.000741	0.00262	CcSEcCtD
Ganciclovir—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000738	0.0026	CcSEcCtD
Ganciclovir—Hypotension—Furosemide—dilated cardiomyopathy	0.000731	0.00258	CcSEcCtD
Ganciclovir—Alopecia—Lisinopril—dilated cardiomyopathy	0.00073	0.00258	CcSEcCtD
Ganciclovir—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000724	0.00255	CcSEcCtD
Ganciclovir—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000719	0.00254	CcSEcCtD
Ganciclovir—Flatulence—Lisinopril—dilated cardiomyopathy	0.000708	0.0025	CcSEcCtD
Ganciclovir—Tension—Lisinopril—dilated cardiomyopathy	0.000705	0.00249	CcSEcCtD
Ganciclovir—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000704	0.00249	CcSEcCtD
Ganciclovir—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000702	0.00248	CcSEcCtD
Ganciclovir—Nervousness—Lisinopril—dilated cardiomyopathy	0.000698	0.00246	CcSEcCtD
Ganciclovir—Back pain—Lisinopril—dilated cardiomyopathy	0.000695	0.00245	CcSEcCtD
Ganciclovir—Somnolence—Furosemide—dilated cardiomyopathy	0.000695	0.00245	CcSEcCtD
Ganciclovir—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000691	0.00244	CcSEcCtD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000685	0.0195	CbGpPWpGaD
Ganciclovir—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00068	0.0024	CcSEcCtD
Ganciclovir—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000678	0.00239	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000675	0.00238	CcSEcCtD
Ganciclovir—Fatigue—Furosemide—dilated cardiomyopathy	0.000674	0.00238	CcSEcCtD
Ganciclovir—Tremor—Lisinopril—dilated cardiomyopathy	0.000674	0.00238	CcSEcCtD
Ganciclovir—Pain—Furosemide—dilated cardiomyopathy	0.000669	0.00236	CcSEcCtD
Ganciclovir—Constipation—Furosemide—dilated cardiomyopathy	0.000669	0.00236	CcSEcCtD
Ganciclovir—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000667	0.00235	CcSEcCtD
Ganciclovir—Anaemia—Lisinopril—dilated cardiomyopathy	0.000664	0.00235	CcSEcCtD
Ganciclovir—Malaise—Lisinopril—dilated cardiomyopathy	0.000648	0.00229	CcSEcCtD
Ganciclovir—Vertigo—Lisinopril—dilated cardiomyopathy	0.000646	0.00228	CcSEcCtD
Ganciclovir—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000644	0.00227	CcSEcCtD
Ganciclovir—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000644	0.00227	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000639	0.00226	CcSEcCtD
Ganciclovir—Cough—Lisinopril—dilated cardiomyopathy	0.000627	0.00221	CcSEcCtD
Ganciclovir—Urticaria—Furosemide—dilated cardiomyopathy	0.000621	0.00219	CcSEcCtD
Ganciclovir—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000618	0.00218	CcSEcCtD
Ganciclovir—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000618	0.00218	CcSEcCtD
Ganciclovir—Chest pain—Lisinopril—dilated cardiomyopathy	0.000612	0.00216	CcSEcCtD
Ganciclovir—Myalgia—Lisinopril—dilated cardiomyopathy	0.000612	0.00216	CcSEcCtD
Ganciclovir—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000612	0.00216	CcSEcCtD
Ganciclovir—Anxiety—Lisinopril—dilated cardiomyopathy	0.00061	0.00215	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000608	0.00215	CcSEcCtD
Ganciclovir—Discomfort—Lisinopril—dilated cardiomyopathy	0.000605	0.00213	CcSEcCtD
Ganciclovir—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000599	0.00211	CcSEcCtD
Ganciclovir—Confusional state—Lisinopril—dilated cardiomyopathy	0.000592	0.00209	CcSEcCtD
Ganciclovir—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000587	0.00207	CcSEcCtD
Ganciclovir—Oedema—Lisinopril—dilated cardiomyopathy	0.000587	0.00207	CcSEcCtD
Ganciclovir—Infection—Lisinopril—dilated cardiomyopathy	0.000583	0.00206	CcSEcCtD
Ganciclovir—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000576	0.00203	CcSEcCtD
Ganciclovir—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000574	0.00203	CcSEcCtD
Ganciclovir—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000573	0.00202	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000571	0.0162	CbGpPWpGaD
Ganciclovir—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00057	0.00201	CcSEcCtD
Ganciclovir—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000567	0.002	CcSEcCtD
Ganciclovir—Asthenia—Furosemide—dilated cardiomyopathy	0.000561	0.00198	CcSEcCtD
Ganciclovir—Anorexia—Lisinopril—dilated cardiomyopathy	0.000559	0.00197	CcSEcCtD
Ganciclovir—Pruritus—Furosemide—dilated cardiomyopathy	0.000553	0.00195	CcSEcCtD
Ganciclovir—Hypotension—Lisinopril—dilated cardiomyopathy	0.000548	0.00194	CcSEcCtD
Ganciclovir—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000535	0.00189	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000535	0.00189	CcSEcCtD
Ganciclovir—Insomnia—Lisinopril—dilated cardiomyopathy	0.000531	0.00187	CcSEcCtD
Ganciclovir—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000527	0.00186	CcSEcCtD
Ganciclovir—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000523	0.00185	CcSEcCtD
Ganciclovir—Somnolence—Lisinopril—dilated cardiomyopathy	0.000522	0.00184	CcSEcCtD
Ganciclovir—Dizziness—Furosemide—dilated cardiomyopathy	0.000517	0.00183	CcSEcCtD
Ganciclovir—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000516	0.00182	CcSEcCtD
Ganciclovir—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00051	0.0018	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000507	0.00179	CcSEcCtD
Ganciclovir—Fatigue—Lisinopril—dilated cardiomyopathy	0.000506	0.00179	CcSEcCtD
Ganciclovir—Pain—Lisinopril—dilated cardiomyopathy	0.000502	0.00177	CcSEcCtD
Ganciclovir—Constipation—Lisinopril—dilated cardiomyopathy	0.000502	0.00177	CcSEcCtD
Ganciclovir—Vomiting—Furosemide—dilated cardiomyopathy	0.000497	0.00176	CcSEcCtD
Ganciclovir—Rash—Furosemide—dilated cardiomyopathy	0.000493	0.00174	CcSEcCtD
Ganciclovir—Dermatitis—Furosemide—dilated cardiomyopathy	0.000493	0.00174	CcSEcCtD
Ganciclovir—Headache—Furosemide—dilated cardiomyopathy	0.00049	0.00173	CcSEcCtD
Ganciclovir—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000484	0.00171	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00048	0.0136	CbGpPWpGaD
Ganciclovir—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00048	0.00169	CcSEcCtD
Ganciclovir—Urticaria—Lisinopril—dilated cardiomyopathy	0.000466	0.00165	CcSEcCtD
Ganciclovir—Nausea—Furosemide—dilated cardiomyopathy	0.000464	0.00164	CcSEcCtD
Ganciclovir—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000464	0.00164	CcSEcCtD
Ganciclovir—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000464	0.00164	CcSEcCtD
Ganciclovir—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000432	0.00153	CcSEcCtD
Ganciclovir—Asthenia—Lisinopril—dilated cardiomyopathy	0.000421	0.00149	CcSEcCtD
Ganciclovir—Pruritus—Lisinopril—dilated cardiomyopathy	0.000415	0.00147	CcSEcCtD
Ganciclovir—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000401	0.00142	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000401	0.0114	CbGpPWpGaD
Ganciclovir—Dizziness—Lisinopril—dilated cardiomyopathy	0.000388	0.00137	CcSEcCtD
Ganciclovir—Vomiting—Lisinopril—dilated cardiomyopathy	0.000373	0.00132	CcSEcCtD
Ganciclovir—Rash—Lisinopril—dilated cardiomyopathy	0.00037	0.00131	CcSEcCtD
Ganciclovir—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00037	0.0013	CcSEcCtD
Ganciclovir—Headache—Lisinopril—dilated cardiomyopathy	0.000368	0.0013	CcSEcCtD
Ganciclovir—Nausea—Lisinopril—dilated cardiomyopathy	0.000349	0.00123	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000342	0.00973	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000311	0.00885	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000298	0.00848	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00029	0.00825	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00029	0.00825	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000274	0.00778	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00027	0.00767	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000262	0.00746	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000251	0.00713	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000244	0.00694	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000244	0.00694	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000227	0.00645	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000209	0.00595	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000204	0.00579	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000204	0.00579	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000189	0.00538	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000163	0.00462	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000158	0.0045	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000158	0.0045	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000147	0.00418	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000107	0.00304	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	0.000101	0.00286	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	9.09e-05	0.00258	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.79e-05	0.00221	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	5.97e-05	0.0017	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.89e-05	0.00167	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.95e-05	0.00141	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.13e-05	0.00117	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.21e-05	0.000912	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	2.47e-05	0.000702	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	2.41e-05	0.000684	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	2.17e-05	0.000616	CbGpPWpGaD
